Når TESAVEL anvendes i kombination med et sulfonylurinstof, kan en lavere dosis af sulfonylurinstoffet overvejes for at reducere risikoen for hypoglykæmi (se pkt.
When TESAVEL is used in combination with a sulphonylurea, a lower dose of the sulphonylurea may be considered to reduce the risk of hypoglycaemia.